ArticleHormones (Athens, Greece)2025
Age-specific relationships between free triiodothyronine and biological aging.
Article in Hormones (Athens, Greece), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Revisiting Thyroid Function in Patients Undergoing Electroconvulsive Therapy for Severe or Treatment-Resistant Depression.Journal of clinical medicine · 2026Article
- Phenotypic Age Acceleration as a Mediator in Thyroid Hormone-Related Cardiovascular Risk Among the Elderly.Cardiology research and practice · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveOur study aims to examine the associations of thyroid function parameters with phenotypic age acceleration (PhenoAgeAccel) in different age groups.
methodThe analysis included 7,564 participants from the NHANES 1999-2018. PhenoAgeAccel was defined as calculated phenotypic age (PhenoAge) exceeding chronological age. Weighted multivariable logistic regression models were used to analyze the relationship between free triiodothyronine (FT3) and PhenoAgeAccel. The restricted cubic spline method was used to assess nonlinear associations of FT3 level with PhenoAgeAccel. Nomogram and the receiver operating characteristic (ROC) curve were constructed to evaluate the diagnostic performance of the predictive model.
resultsHigher FT3 levels were associated with increased risk of PhenoAgeAccel in participants under 60 years old (OR: 1.316, 95% CI: (1.010, 1.715), p = 0.042). For those aged 60 years and above, higher FT3 levels were linked with decreased risk of PhenoAgeAccel (OR: 0.485, 95% CI: (0.309, 0.761), p = 0.002). These associations were more pronounced in males than in females. Restricted cubic spline curves showed similar trends between FT3 levels and PhenoAgeAccel in both age subgroups. The ROC curves including FT3 indicated that both models had fair prediction performance (age > = 60 years, AUC = 0.722 (0.700-0.743); age < 60 years, AUC = 0.765 (0.751- 0.780)).
conclusionThis study revealed a novel age-dependent association between FT3 levels and biological aging acceleration, with lower FT3 potentially serving as a biomarker for accelerated aging in elderly individuals, while an inverse relationship was observed in younger adults. The study provides novel insights into the intricate relationship between thyroid function and systemic health across the lifespan.
Indexed as
Identifiers
40332749What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.